| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jun 4, 2017Virtual Press Office and PR Newswire: General Trade show news
Encouraging results from a Phase 2 randomized, multi-center clinical trial in pancreas cancer patients conducted by Halozyme Therapeutics (NASDAQ: HALO) were presented today at the American...
-
Jun 4, 2017Virtual Press Office and PR Newswire: General Trade show news
Janssen Research & Development, LLC today announced new data from updated analyses of the pivotal Phase 3 CASTOR and POLLUX clinical studies, demonstrating that DARZALEX® (daratumumab) in...
-
Jun 4, 2017Virtual Press Office and PR Newswire: General Trade show news
Oral presentation provides first REGN2810 data in patients with advanced cutaneous squamous cell carcinoma (CSCC) Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi today announced positive...
-
Jun 4, 2017Virtual Press Office and PR Newswire: General Trade show news
Sanofi and Regeneron Pharmaceuticals, Inc. today announced positive preliminary results with investigational REGN2810, a checkpoint inhibitor targeting PD-1 (programmed death 1), in patients with...
-
Jun 4, 2017Virtual Press Office and PR Newswire: General Trade show news
The first International Style Conference was jointly held in Niccolo Chengdu by T China and Chengdu International Finance Square (Chengdu IFS), dedicated to explore Style Transformation in China...
